D

Definitive Healthcare Corp. DH

$1.31 $0.064.80% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$1.24$1.32
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

DH Rating

Reward
Risk

DH Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

DH Company Overview

Definitive Healthcare Corp. is a U.S.-based healthcare commercial intelligence and data analytics company that provides data, analytics, and workflow tools to organizations operating across the healthcare ecosystem. The company primarily serves pharmaceutical manufacturers, medical device companies, healthcare providers, health insurers, consulting firms, and healthcare technology vendors. Its platform aggregates and analyzes healthcare provider, claims, prescription, and market intelligence data to support sales targeting, market research, care coordination, and commercial strategy. Definitive Healthcare operates within the healthcare information services and healthcare technology industries, with recurring subscription revenue serving as its primary revenue driver.

The company’s core offerings include provider and hospital intelligence, physician and claims data, commercial analytics, and workflow integration tools delivered through cloud-based software platforms. Definitive Healthcare has positioned itself as a healthcare-specific intelligence provider with broad proprietary datasets and integrated analytics capabilities that support customer acquisition and commercialization efforts across healthcare markets. Founded in 2011 and headquartered in Framingham, Massachusetts, the company expanded through organic product development and acquisitions before completing its initial public offering in 2021. Public disclosures, including SEC filings, indicate that the company’s growth strategy has focused on expanding data coverage, increasing platform integration, and broadening customer penetration across life sciences and healthcare services markets.

Data compiled by narrative technology. May contain errors.
Sector

DH Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

DH Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

DH Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

DH Price History

Loading...
52-Week Range29% of range
Current
$1.31
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

DH Valuation

Market Cap
Market Cap Rank
#10,445
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

DH Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

DH Corporate Info

Phone Number
508 720 4224
Address
492 Old Connecticut Path
Suite 401
Framingham, MA 01701
Country
Year Founded

DH Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

DH Headlines